EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploring Microbial Metabolite Receptors in Inflammatory Bowel Disease: An In Silico Analysis of Their Potential Role in Inflammation and Fibrosis

Michail Spathakis, Nikolas Dovrolis iD, Eirini Filidou iD, Leonidas Kandilogiannakis iD, Gesthimani Tarapatzi iD, Vassilis Valatas, Ioannis Drygiannakis, Vasilis Paspaliaris, Konstantinos Arvanitidis iD, Vangelis G Manolopoulos iD, George Kolios iD, Stergios Vradelis iD

Pharmaceuticals · 12.04.2024 · 17 (4) · 492

DOI: 10.3390/ph17040492 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 12.04.2024. Verfasst von Michail Spathakis und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Pharmacology, Faculty of Medicine, Democritus University of Thrace, 68100 Alexandroupolis, Greece. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Establishment of a Center of Excellence for Pharmacological Studies and Precision Medicine - IMPReS" (MIS 5047189) which is implemented under the Action "Suppo…, Establishment of a Center of Excellence for Pharmacological Studies and Precision Medicine-IMPReS, Competitiveness, Entrepreneurship and Innovation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolites produced by dysbiotic intestinal microbiota can influence disease pathophysiology by participating in ligand–receptor interactions. Our aim was to investigate the differential expression of metabolite receptor (MR) genes between inflammatory bowel disease (IBD), healthy individuals (HIs), and disease controls in order to identify possible interactions with inflammatory and fibrotic pathways in the intestine. RNA-sequencing datasets containing 643 Crohn’s disease (CD) patients, 467 ulcerative colitis (UC) patients and 295 HIs, and 4 Campylobacter jejuni-infected individuals were retrieved from the Sequence Read Archive, and differential expression was performed using the RaNA-seq online platform. The identified differentially expressed MR genes were used for correlation analysis with up- and downregulated genes in IBD, as well as functional enrichment analysis using a R based pipeline. Overall, 15 MR genes exhibited dysregulated expression in IBD. In inflamed CD, the hydroxycarboxylic acid receptors 2 and 3 (HCAR2, HCAR3) were upregulated and were associated with the recruitment of innate immune cells, while, in the non-inflamed CD ileum, the cannabinoid receptor 1 (CNR1) and the sphingosine-1-phospate receptor 4 (S1PR4) were downregulated and were involved in the regulation of B-cell activation. In inflamed UC, the upregulated receptors HCAR2 and HCAR3 were more closely associated with the process of TH-17 cell differentiation, while the pregnane X receptor (NR1I2) and the transient receptor potential vanilloid 1 (TRPV1) were downregulated and were involved in epithelial barrier maintenance. Our results elucidate the landscape of metabolite receptor expression in IBD, highlighting associations with disease-related functions that could guide the development of new targeted therapies.

Schlagwörter

Stichwörter der Autor:innen

inflammationinflammatory bowel diseasemetabolite receptorsmetabolitesmicrobiota

Autor:innen und Institutionen

  • Laboratory of Pharmacology, Faculty of Medicine, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
  • Individualised Medicine & Pharmacological Research Solutions Center (IMPReS), 68100 Alexandroupolis, Greece.
  • Gastroenterology and Hepatology Research Laboratory, Medical School, University of Crete, 71003 Heraklion, Greece.
  • Tithon Biotech Inc., San Diego, CA 92127, USA.
  • Department of Internal Medicine, University Hospital of Alexandroupolis, Democritus University of Thrace, 68100 Alexandroupolis, Greece.

ORCID-Profile: Nikolas Dovrolis, Eirini Filidou, Leonidas Kandilogiannakis, Gesthimani Tarapatzi, Konstantinos Arvanitidis, Vangelis G Manolopoulos, George Kolios, Stergios Vradelis

Förderung

  • Establishment of a Center of Excellence for Pharmacological Studies and Precision Medicine - IMPReS" (MIS 5047189) which is implemented under the Action "Suppo…
  • Establishment of a Center of Excellence for Pharmacological Studies and Precision Medicine-IMPReS
  • Competitiveness, Entrepreneurship and Innovation
  • Greece and the European Union (European Regional Development Fund)

Zitieren

APA

Spathakis, M., Dovrolis, N., Filidou, E., Kandilogiannakis, L., Tarapatzi, G., Valatas, V., Drygiannakis, I., Paspaliaris, V., Arvanitidis, K., Manolopoulos, V. G., Kolios, G., & Vradelis, S. (2024). Exploring Microbial Metabolite Receptors in Inflammatory Bowel Disease: An In Silico Analysis of Their Potential Role in Inflammation and Fibrosis. Pharmaceuticals, 17(4), 492. https://doi.org/10.3390/ph17040492

Vancouver

Spathakis M, Dovrolis N, Filidou E, Kandilogiannakis L, Tarapatzi G, Valatas V, et al. Exploring Microbial Metabolite Receptors in Inflammatory Bowel Disease: An In Silico Analysis of Their Potential Role in Inflammation and Fibrosis. Pharmaceuticals. 2024;17(4):492. doi:10.3390/ph17040492

BibTeX
@article{Spathakis2024,
  author = {Spathakis, Michail and Dovrolis, Nikolas and Filidou, Eirini and Kandilogiannakis, Leonidas and Tarapatzi, Gesthimani and Valatas, Vassilis and Drygiannakis, Ioannis and Paspaliaris, Vasilis and Arvanitidis, Konstantinos and Manolopoulos, Vangelis G and Kolios, George and Vradelis, Stergios},
  title = {Exploring Microbial Metabolite Receptors in Inflammatory Bowel Disease: An In Silico Analysis of Their Potential Role in Inflammation and Fibrosis},
  journal = {Pharmaceuticals},
  year = {2024},
  volume = {17},
  number = {4},
  pages = {492},
  doi = {10.3390/ph17040492}
}
Kostenlos starten →